Department of Medicine, Hypertension Unit, Hadassah-Hebrew University Medical Center, Mount-Scopus, Jerusalem, Israel.
Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
J Hypertens. 2020 Jul;38(7):1286-1292. doi: 10.1097/HJH.0000000000002366.
Twenty-four-hour ambulatory pulse pressure (PP) is a powerful predictor of outcome. We attempted to apply the recently described PP components, an elastic (elPP), and systolic stiffening (stPP) components from 24-h ambulatory blood pressure (BP) monitoring (AMBP), and examine their influence on outcome in the Ohasama study population.
Included were participants of the Ohasama study without history of cardiovascular disease (CVD), who were followed-up for total and CVD mortality, and for stroke morbidity. The PP components were derived from 24-h SBP and DBP using a model based on the nonlinear pressure--volume relationship in arteries expressing pressure stiffness relationship. Outcome predictive power was estimated by Cox regression models; hazard ratio with 95% confidence interval (CI), applied to elPP, and stPP, adjusted for age, sex, BMI, smoking, alcohol drinking, diabetes mellitus, total cholesterol, antihypertensive treatment, and mean arterial pressure (MAP), whenever appropriate.
Of 1745 participants (age 61.4 ± 11.6, 65% women), 580 died, 212 of CVD, and 290 experienced a stroke during 17 follow-up years. PP was strongly correlated with elPP (r = 0.89) and less so with stPP (r = 0.58), and the correlation between the two components was weak (r = 0.15). After the adjustment, hazard ratio of PP per 1 SD increment for total mortality, CVD mortality, and stroke morbidity were 1.095 (95% CI 0.973-1.232), 1.207 (1.000-1.456), and 0.983 (0.829-1.166), respectively. Corresponding hazard ratios and 95% CIs were nonsignificant for elPP, and stPP. However, among participants with median pulse rate 68.5 bpm or less (median, n = 872), total (327 deaths) and CVD (131 deaths) mortality were predicted by elPP (per 1 SD increment), hazard ratio 1.231 (95% CI, 1.082-1.401), and 1.294 (95% CI, 1.069-1.566), respectively. In the subgroup of treated participants with hypertension and pulse rate 68.5 or less bpm (n = 309), total (177 deaths) and CVD (77 deaths) mortality were predicted by elPP, hazard ratio of 1.357 (95% CI, 1.131-1.628), and 1.417 (95% CI, 1.092-1.839), respectively. Stroke morbidity was not predicted by either PP or the PP components.
In a rural Japanese population, elPP but not stPP was predictive of total and CVD mortality even when adjusted for MAP and conventional risk factors in the subpopulation with slower pulse rate. This was mostly among the treated hypertensive patients.
24 小时动态脉压(PP)是预后的有力预测指标。我们试图应用最近描述的 PP 成分,即来自 24 小时动态血压监测(AMBP)的弹性(elPP)和收缩僵硬(stPP)成分,并在大崎研究人群中检查它们对结局的影响。
本研究纳入了无心血管疾病(CVD)病史的大崎研究参与者,随访总死亡率和 CVD 死亡率以及卒中发病率。使用基于动脉中压力-体积关系表达压力僵硬关系的模型,从 24 小时 SBP 和 DBP 中得出 PP 成分。通过 Cox 回归模型估计预后预测能力;危险比(HR)和 95%置信区间(CI)适用于 elPP 和 stPP,调整因素包括年龄、性别、BMI、吸烟、饮酒、糖尿病、总胆固醇、降压治疗和平均动脉压(MAP),如果适用。
在 1745 名参与者(年龄 61.4±11.6,65%为女性)中,580 人死亡,212 人死于 CVD,290 人在 17 年的随访中发生卒中。PP 与 elPP 高度相关(r=0.89),与 stPP 相关性较低(r=0.58),两者之间的相关性较弱(r=0.15)。调整后,PP 每增加 1 个 SD,总死亡率、CVD 死亡率和卒中发病率的 HR 分别为 1.095(95%CI 0.973-1.232)、1.207(1.000-1.456)和 0.983(0.829-1.166)。elPP 和 stPP 的相应 HR 和 95%CI 均无统计学意义。然而,在脉搏率中位数为 68.5bpm 或更低的参与者中(中位数,n=872),elPP(每增加 1 个 SD)预测总死亡率(327 例死亡)和 CVD 死亡率(131 例死亡),HR 分别为 1.231(95%CI,1.082-1.401)和 1.294(95%CI,1.069-1.566)。在接受治疗的高血压和脉搏率为 68.5bpm 或更低的亚组参与者中(n=309),elPP 预测总死亡率(177 例死亡)和 CVD 死亡率(77 例死亡),HR 分别为 1.357(95%CI,1.131-1.628)和 1.417(95%CI,1.092-1.839)。PP 和 PP 成分均不能预测卒中发病率。
在日本农村人群中,即使在校正了脉搏率较慢的亚组中的 MAP 和传统危险因素后,elPP 而不是 stPP 也可以预测总死亡率和 CVD 死亡率。这主要发生在接受治疗的高血压患者中。